RNA FY 2022 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-1.1% YoY

Gross Profit

$8M85.0% margin

Operating Income

-$179M-1939.6% margin

Net Income

-$174M-1886.3% margin

EPS (Diluted)

$-3.34

Cash Flow

Operating Cash Flow

-$136M

Free Cash Flow

-$139M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$639M

Total Liabilities

$61M

Stockholders' Equity

$578M

Cash & Equivalents

$340M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$9M	-1.1%
Gross Profit	$8M	-$92M	+108.5%
Operating Income	-$179M	-$118M	-51.6%
Net Income	-$174M	-$118M	-47.4%